A recent study examined the vaginal bacteria in HIV-uninfected women to determine if the presence of certain bacteria reduced or increased the risk for HIV infection.
A multicenter phase 1/2 trial evaluated the acceptability and tolerability of long-acting injectable cabotegravir–rilpivirine over 48 weeks in adolescents with HIV-1, focusing on patient-reported pain,...
A new analysis of US claims data examined preexposure prophylaxis prescribing patterns among commercially insured adolescents and young adults at increased risk for HIV, offering clinicians insights into...
New research weighed the benefits and harms of beginning antiretroviral therapy immediately in HIV positive individuals, rather than relying on CD4+ cell counts to determine when to begin treatment.